Syntec Optics (OPTX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Feb, 2026Executive summary
Achieved net sales of $7.1 million for Q1 2025, a 13% increase year-over-year, driven by growth in medical and defense end markets, partially offset by a decline in communications.
Net income improved to $0.3 million from a loss of $1.2 million in Q1 2024, reflecting higher gross profit and lower general and administrative expenses.
Focus remains on vertically integrated manufacturing for optics and photonics, with continued expansion in defense, medical, consumer, and communications markets.
Financial highlights
Gross profit rose 226% year-over-year to $2.3 million, with gross margin improving to 33% from 11%.
General and administrative expenses decreased 16% to $1.8 million, mainly due to lower advertising and consulting costs.
Adjusted EBITDA was $1.4 million (20% of revenue), up from negative $0.4 million (-6%) in Q1 2024.
Cash at quarter-end was $0.5 million, with $1.7 million available on the line of credit.
Outlook and guidance
Plans to pursue bolt-on acquisitions for inorganic growth in the fragmented photonics industry.
Anticipates further sales growth as product and system offerings expand and customer demand for sophisticated solutions increases.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, RSU grants, and governance amendments.OPTX
Proxy Filing29 Nov 2025